RedLine Pharmacovigilance

What RedLine Pharmacovigilance does

Red Line Pharmacovigilance (legal entity: Red Line Ltd, registered in England & Wales, Company No. 07395811) is a UK-based B2B outsourcing partner that delivers pharmacovigilance, medical information, literature monitoring, and medical device vigilance services to pharmaceutical companies and medical device manufacturers. Founded in 2010 and operating from a single headquarters in Milton Keynes, the firm serves as an outsourced Qualified Person for Pharmacovigilance (QPPV) and a regulatory compliance provider for Marketing Authorisation Holders seeking to meet EU and UK pharmacovigilance obligations across both human medicinal products and medical devices. The stated customer base spans "large and small" pharmaceutical industry clients, with services tailored to individual client needs, budgets, and legislative requirements.

The service portfolio is organised around six core offerings: (1) QPPV and pharmacovigilance services covering adverse event case handling, MedDRA coding, ICSR processing, expedited reporting, aggregate report compilation (PSURs, PADERs), signal detection, and risk management planning; (2) medical information enquiry handling, delivered via a computerised telecommunication system; (3) literature monitoring using a proprietary Literature Monitoring System (LMS) with a Weekly Alert Manager; (4) medical device vigilance for IVD, ATP, and combination products; (5) Eudravigilance and MHRA E-Submissions registration plus E2B electronic reporting and XEVMPD maintenance; and (6) training services delivered through a separate online portal (redline-training.co.uk) with CPD-certified courses. The technology stack is built in-house and includes the LMS, the Medical Enquiry Tracking System (METS) with full audit trails, the Weekly Alert Manager, and a multi-factor authenticated client portal. The company also holds a published GDPR compliance statement.

The business model is professional services outsourcing on tailored contracts. Revenue is generated through flexible arrangements — short-term, long-term, and ad-hoc support — that can supplement an existing client pharmacovigilance department or manage part or all of a client's product portfolio. Pricing is not publicly disclosed. The firm employs 1–10 staff, has no external funding on record, no disclosed parent company, and no M&A activity, consistent with an owner-operated, organically funded operating model. Marketing is conducted primarily through the company website and the training portal, with direct phone, email, and in-person contact handling bottom-of-funnel enquiries.

Name

RedLine Pharmacovigilance

Legal name

Red Line Ltd

Website

https://redlinepv.co.uk

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Red Line Pharmacovigilance is a UK-based B2B outsourcing partner providing pharmacovigilance, QPPV, medical information, literature monitoring, and medical device vigilance services to pharmaceutical companies and device manufacturers across the UK and EU markets.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-Management Services (8741)

akta.pro primary industry

Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

akta.pro secondary industries

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF), Safety & Medical Contact Centers (AE Intake/Call Centers) (HLAGALAI), Pharmacovigilance & Drug Safety Software (HLAGAJAK), Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)

Keywords

• Pharmacovigilance services
• Medical information handling
• Literature monitoring
• QPPV services
• Medical device vigilance

Headquarters

HQ city

Milton Keynes

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Pharmacovigilance Outsourcing Services: Comprehensive outsourcing services including QPPV support, adverse event handling, aggregate report compilation, signal detection, and risk management plans. Services can support existing departments or manage part or all of a client's product portfolio. Packages are tailored to client needs, budget, and legislative requirements.
2. Medical Information Services: Enquiry handling services ranging from general enquiries to technical clinical responses, product information packs, and clinical information distribution. Flexible service provision including short/long term contracts, out of hours coverage, and ad-hoc support.
3. Literature Monitoring Services: Weekly literature searches forming part of pharmacovigilance surveillance. Retrospective searches managed as added service. Ongoing product surveillance using weekly Alert Manager.
4. Medical Device Vigilance Services: Risk management support for collection, triage, investigation and reporting of incidents related to medical devices, IVD, ATP or combination products. Includes trend and impact assessments and liaison with regulatory authorities.
5. Training Services: Online courses via training portal ranging from introduction to PV for non-PV staff through to advanced topics. Face-to-face in-house training tailored to business requirements. Certificates awarded on successful completion counting towards company CPD requirements.
6. Eudravigilance Services: Registration with regulatory portals (Eudravigilance, MHRA E-Submissions), electronic adverse event reporting (E2B), and XEVMPD product licence maintenance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

RedLine Pharmacovigilance is a B2B outsourcing partner that delivers pharmacovigilance and medical information services to pharmaceutical companies and medical device manufacturers. Its core offerings include Qualified Person for Pharmacovigilance (QPPV) oversight, adverse event case handling, literature monitoring, Eudravigilance/MHRA regulatory reporting, and CPD-accredited training, supported by proprietary in-house systems such as the Literature Monitoring System (LMS) and Medical Enquiry Tracking System (METS).

Product overview

RedLine Pharmacovigilance is a pharmacovigilance outsourcing provider offering a suite of integrated services for the pharmaceutical industry. The core offering consists of QPPV Services, Pharmacovigilance Services, Medical Information Enquiry Handling, Literature Monitoring System (LMS), Eudravigilance Services, Medical Device Vigilance, and Training Services. These are supported by technology platforms including the Client Portal Login (with multi-factor authentication), Medical Enquiry Tracking System (METS), and Literature Monitoring System (LMS). The company also provides supplementary services including external auditing, SOP writing support, medical writing projects, and staff training. Services cover both human medicinal products and medical devices, with packages tailored to client needs and budget.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacovigilance Services
• Qualified Person for Pharmacovigilance (QPPV) Services
• Medical Information Enquiry Handling
• Literature Monitoring Service
• Medical Device Vigilance Services
• Eudravigilance Services
• Pharmacovigilance Training Services

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Arriello: European pharmacovigilance and regulatory affairs consultancy providing QPPV, case processing, device vigilance, and compliance services. Closely aligned with Red Line on service portfolio, target client segment (small/mid MAHs), and EU regulatory expertise.
• PharSafer: UK-based pharmacovigilance service provider offering QPPV services, drug safety, medical information, and audit support to MAHs globally. Comparable boutique PV outsourcing model with similar European regulatory focus and client profile.
• PrimeVigilance: Specialist pharmacovigilance CRO offering outsourced QPPV, case processing, aggregate reports, signal detection, and risk management for pharmaceutical companies. Most direct boutique PV peer to Red Line with comparable service scope and target customer base of small-to-mid MAHs.
• NDA Group: European regulatory and pharmacovigilance consultancy with a dedicated PV service line covering QPPV, signal management, and medical writing. Comparable boutique services firm targeting similar MAH clients in EU/UK.
• Biopharma Excellence (a Pharmalex company): Regulatory and pharmacovigilance services provider offering PV, regulatory affairs, and quality compliance for pharma companies. Direct competitor in EU PV outsourcing market with overlapping service lines.

Broad incumbents

• IQVIA: World's largest CRO with integrated pharmacovigilance and safety services covering case management, aggregate reporting, signal detection, and risk management across global markets. Key competitive incumbent in PV outsourcing space.
• Parexel International: Major global CRO providing comprehensive pharmacovigilance, regulatory, and clinical safety services to large and mid-sized pharmaceutical companies. Broad incumbent competing in the same PV outsourcing category.
• ICON plc: Global CRO offering full-service clinical, regulatory, and pharmacovigilance capabilities including QPPV, case processing, and signal detection. Represents the enterprise-scale competitive incumbent that Red Line competes against for larger MAH mandates.

Emerging players

• ProPharma Group: Mid-sized pharmacovigilance, regulatory, and compliance consulting firm serving pharma, biotech, and medical device companies. Comparable PV outsourcing focus but larger scale and broader geographic reach than Red Line.
• Vigilare Biologics: Specialized PV and biologics safety services provider focused on advanced therapy and biologic products. Comparable niche PV offering but with a narrower therapeutic focus than Red Line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/red-line-pharmacovigilance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RedLine Pharmacovigilance